Fundraising FoxISA Pharmaceuticals
3 known investors
Find your way into ISA Pharmaceuticals
Sign up to find every way you can get introduced to ISA Pharmaceuticals
- Your email: who you already know at ISA Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ISA Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Netherlands-based developer of fully synthetic immune therapies against cancer and persistent viral infections using a synthetic long peptide platform.
Investors · 3
Cancer Focuslisted by Cancer FocusHouston
How we know: Cancer Focus's portfolio page · prnewswire.com · isa-pharma.com · Not right? Tell us
Invest-NLreportedAmsterdam
How we know: prnewswire.com · Not right? Tell us
Also in the syndicate · 1
Regeneron
Funding
SEC filings, press & company announcements$5M disclosed across 1 of 2 rounds · 2021–2023
- $5MraisedJan 2023 · 2 sourcesSource ↗
- Undisclosed amountfunding roundJul 2021 · 2 sources
Invest-NL, Regeneron
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does ISA Pharmaceuticals do?
- Netherlands-based developer of fully synthetic immune therapies against cancer and persistent viral infections using a synthetic long peptide platform.
- Who are ISA Pharmaceuticals's investors?
- ISA Pharmaceuticals's investors include Cancer Focus, Invest-NL.
- How much funding has ISA Pharmaceuticals raised?
- ISA Pharmaceuticals has disclosed $5M raised across 1 of its 2 known rounds.